Daniel Abdun-Nabi, CEO, Director at Emergent Biosolutions, holds 144.55K shares in Emergent Biosolutions (Ticker: EBS), holds ― shares in RegenXBio (Ticker: RGNX), holds 109.35K shares in Aptevo Therapeutics (Ticker: APVO).
What is the percentage of profitable transactions made by Daniel Abdun-Nabi?
The percentage of profitable transactions made by Daniel Abdun-Nabi is 44%.
What is the average return per transaction made by Daniel Abdun-Nabi?
The average return per transaction made by Daniel Abdun-Nabi is 9.40%.
What stocks does Daniel Abdun-Nabi hold?
Daniel Abdun-Nabi holds: EBS, RGNX, APVO stocks.
What was Daniel Abdun-Nabi’s latest transaction?
Daniel Abdun-Nabi latest transaction was an Uninformative Sell of $846.23K.
What was Daniel Abdun-Nabi's most profitable transaction?
Daniel Abdun-Nabi’s most profitable transaction was an Informative Buy of EBS stock on January 12, 2017. The return on the trade was 57.40%.
What is Daniel Abdun-Nabi's role in Emergent Biosolutions?
Daniel Abdun-Nabi's role in Emergent Biosolutions is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.